Seizert Capital Partners LLC Lowers Stock Holdings in Cigna Group $CI
by Renee Jackson · The Cerbat GemSeizert Capital Partners LLC lowered its position in shares of Cigna Group (NYSE:CI – Free Report) by 3.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 188,582 shares of the health services provider’s stock after selling 7,424 shares during the period. Cigna Group comprises about 2.2% of Seizert Capital Partners LLC’s holdings, making the stock its 18th largest holding. Seizert Capital Partners LLC owned approximately 0.07% of Cigna Group worth $51,903,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Brighton Jones LLC boosted its stake in Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC grew its position in Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after acquiring an additional 109 shares during the last quarter. NewEdge Advisors LLC raised its stake in shares of Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after acquiring an additional 958 shares in the last quarter. Treasurer of the State of North Carolina lifted its holdings in shares of Cigna Group by 16.6% in the 2nd quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after acquiring an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. purchased a new stake in shares of Cigna Group in the 2nd quarter valued at $163,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
Cigna Group Trading Up 0.1%
NYSE:CI opened at $283.14 on Monday. The firm has a market capitalization of $74.62 billion, a P/E ratio of 12.00, a P/E/G ratio of 0.98 and a beta of 0.30. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a fifty day moving average of $274.34 and a 200 day moving average of $276.63. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00.
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, research analysts predict that Cigna Group will post 30.41 earnings per share for the current year.
Cigna Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 28.13%.
Insider Transactions at Cigna Group
In other news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several research firms recently commented on CI. Wells Fargo & Company increased their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a report on Friday. Piper Sandler cut their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Robert W. Baird set a $337.00 price objective on Cigna Group in a research note on Friday. Truist Financial lifted their price objective on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Finally, Guggenheim restated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $336.20.
View Our Latest Research Report on Cigna Group
Trending Headlines about Cigna Group
Here are the key news stories impacting Cigna Group this week:
- Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
- Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
- Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
- Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
- Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
- Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
- Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.